BioCorRx Provides Update on Current Business Operations and on GLP Studies of BICX102; Uninterrupted by COVID-19 Pandemic May 22, 2020
BioCorRx Offers Free Access to the UnCraveRx™ Mobile Platform for Weight Loss Management During COVID-19 Pandemic Apr 10, 2020
BioCorRx Offers Free Access to the BioCorRx Recovery Program Mobile Platform for Medical Professionals During COVID-19 Pandemic Apr 7, 2020
BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic Mar 31, 2020
BioCorRx Announces Award of $2.8 Million, the Second Tranche of a NIDA Grant for the Development of BICX102, a Sustained Release Naltrexone Implant for the Treatment of Opioid Use Disorder Jan 30, 2020
BioCorRx’s Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001 Dec 3, 2019
BioCorRx Announces UnCraveRx™ a Medically-Assisted Weight Loss Program as Sponsor and Exhibitor at the 36th Annual American Society of Metabolic and Bariatric Society Meeting Oct 30, 2019
BioCorRx Announces the Official Launch of UnCraveRx, a Medically-Assisted Weight Loss Management Program Oct 8, 2019
